Search
Close this search box.

Araclon Biotech, new partner of Arahealth

Araclon Biotech joins Arahealth as a “collaborating partner” within the agreement we reached with Arabiotech in 2023. It has consolidated its position as a pioneering company in the development of projects in the diagnosis and treatment of Alzheimer’s disease and since 2012 it has had the participation of the multinational Grifols in its shareholding.

Arahealth obtains €1.7M for innovation projects

We have just received the provisional resolutions of the grants for clusters from the Ministry of Industry for collaborative R+D projects where Arahealth has been granted everything requested. A grant of €1.7M for a total budget of €2.4M from the six projects led by Arahealth and the other two in which we participate but are … Read more